The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world analysis of VTE incidence in lung cancer: A comprehensive assessment of the Khorana score and other clinical factors in predicting VTE incidence.
 
Rishika Singh
No Relationships to Disclose
 
Caleb McKinney
No Relationships to Disclose
 
Sean Dougherty
No Relationships to Disclose
 
Nathan Roberts
No Relationships to Disclose
 
Jack Masur
No Relationships to Disclose
 
Aditya Singh
No Relationships to Disclose
 
Alia Lynch
No Relationships to Disclose
 
Ryan Gentzler
Honoraria - Academy of Continued Healthcare Learning; Aptitude Health; BioAscent; Curio Science; MedStar Georgetown University Hospital; OncLive
Consulting or Advisory Role - Amgen; AstraZeneca; Genentech; Merus; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dizal Pharma; Janssen (Inst); Jounce Therapeutics (Inst); Merck (Inst); nalo therapeutics; Pfizer (Inst); Puma Biotechnology; RTI International (Inst); Takeda (Inst); Tempus
Travel, Accommodations, Expenses - Tempus
 
Wendy Novicoff
No Relationships to Disclose
 
Richard Hall
Consulting or Advisory Role - Bayer; EMD Serono; Regeneron; Takeda
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Daiichi Sankyo/Lilly (Inst); Genentech (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Regeneron (Inst)